Guangzhou Kaiduo Investment Advisory Center cancelled the acquisition of an additional 6.59% stake in Guangzhou LBP Medical Technology Co,. Ltd from Da An Gene Co Ltd..
January 12, 2013 at 11:00 pm
Share
Guangzhou Kaiduo Investment Advisory Center entered into an agreement to acquire an additional 6.59% stake in Guangzhou LBP Medical Technology Co,. Ltd (LBP) from Da An Gene Co Ltd. (SZSE:002030) for CNY 19.3 million on January 13, 2012. Within 10 working days after the signing of the agreement, Guangzhou Kaiduo Investment Advisory Center must deposit 30% to LBP's designated account and the remaining 70% balance will be paid within another agreed upon period. After the transaction, Guangzhou Kaiduo Investment Advisory Center will hold 22.02% stake and Da An Gene Co Ltd will hold 33.31% stake in Guangzhou LBP Medical Technology Co,. Ltd.
Guangzhou Kaiduo Investment Advisory Center cancelled the acquisition of an additional 6.59% stake in Guangzhou LBP Medical Technology Co,. Ltd (LBP) from Da An Gene Co Ltd. (SZSE:002030) on January 13, 2013.
Guangzhou LBP Medicine Science & Technology Co Ltd is a China-based company mainly engaged in the research, development, production and sales of in vitro diagnostic reagents and instruments. The Companyâs main products are pathological diagnostic reagents and instruments, covering three major technology platforms for cytological diagnosis, molecular diagnosis and immunodiagnosis, including LBP series, IHC series, PCR series and FISH series, such as integrated slide and dyeing machine, liquid-based cell and microorganism processing, preservation reagents, automatic nucleic acid molecular hybridization instrument, automatic slide processing system and immunochromogenic reagents, etc. Its products are mainly used in pathological diagnosis of tumors. The Company operates its businesses within the domestic market and to overseas markets.
Guangzhou Kaiduo Investment Advisory Center cancelled the acquisition of an additional 6.59% stake in Guangzhou LBP Medical Technology Co,. Ltd from Da An Gene Co Ltd..